Compare REXR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REXR | TXG |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | 256 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.5B |
| IPO Year | 2013 | 2019 |
| Metric | REXR | TXG |
|---|---|---|
| Price | $36.21 | $88.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 19 |
| Target Price | $40.38 | ★ $58.80 |
| AVG Volume (30 Days) | 2.4M | ★ 2.6M |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.80% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,003,133,000.00 | $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 7.13 | ★ 68.06 |
| 52 Week Low | $32.14 | $11.17 |
| 52 Week High | $44.38 | $94.54 |
| Indicator | REXR | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 78.04 |
| Support Level | $36.19 | $74.60 |
| Resistance Level | $36.65 | N/A |
| Average True Range (ATR) | 0.79 | 5.41 |
| MACD | -0.26 | 1.13 |
| Stochastic Oscillator | 4.76 | 88.85 |
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).